OraPharma, a number one oral care firm of Bausch Well being Firms Inc. (NYSE.TSX:BHC), at the moment introduced the U.S. launch of the MyPerioHealth app, a first-of-its variety interactive oral well being academic device that enables sufferers at the side of their dental professionals a fast and straightforward approach to perceive the stage and grade of periodontal disease on a single, digital platform on the level of care.
“The MyPerioHealth training app was designed as a useful resource for dental professionals when utilizing the Periodontal Staging and Grading Pointers established by the American Academy of Periodontology to assist encourage dialogue and supply an interactive oral well being evaluation in a affected person pleasant, transportable means,” stated Dinesh Guglani, vice chairman and basic supervisor, OraPharma. “By responding to a sequence of brief questions, a affected person and their dental care skilled can acquire a wealth of essential info relating to the affected person’s periodontal well being standing, together with the stage and grade, that are very important for remedy planning and figuring out the upkeep interval to assist handle the illness.”
The AAP Pointers are supposed for sufferers who’ve already been recognized with periodontitis. The MyPerioHealth app enhances handbook staging and grading by streamlining information assortment and automating calculations utilizing the American Academy of Periodontology pointers. The app will assist enhance sufferers’ consciousness of gum illness by encouraging dialogue and collaboration between dental professionals and their sufferers.
“The MyPerioHealth™ app will assist improve the understanding of periodontal illness by offering sufferers with the power to have higher understanding and possession of their illness. Armed with their periodontal rating and the ramifications of unchecked periodontal illness, we consider sufferers will likely be extra accepting of the remedy suggestions they obtain from their docs.” Guglani continued.
Designed to be used on a pill or cellular phone, the MyPerioHealth™ app is offered on each iOS and Android platforms. It may be downloaded from the Google Play Retailer, Apple App Retailer or Amazon Appstore. An internet-based model may also be accessed at www.myperiohealth.com.
OraPharma, a number one oral care firm of Bausch Well being Firms Inc., is devoted to growing revolutionary options in oral care to assist dental well being care professionals and sufferers. By specializing in enhancing sufferers’ lives by means of the connection between oral care and general well being, OraPharma presents a complete suite of merchandise that assist handle sufferers’ oral well being issues.
These merchandise embody ARESTIN® (minocycline HCl) Microspheres, 1 mg, NeutraSal® (supersaturated calcium phosphate rinse) and XERESE® (acyclovir and hydrocortisone) cream 5%/1%. For extra info on OraPharma, go to www.orapharma.com.
This information launch could include forward-looking statements, which can usually be recognized by means of the phrases “anticipates,” “hopes,” “expects,” “intends,” “plans,” “ought to,” “may,” “would,” “could,” “believes,” “estimates,” “potential,” “goal,” or “proceed” and variations or related expressions. These statements are primarily based upon the present expectations and beliefs of administration and are topic to sure dangers and uncertainties that would trigger precise outcomes to vary materially from these described within the forward-looking statements.
These dangers and uncertainties embody, however aren’t restricted to, the dangers and uncertainties mentioned in Bausch Well being’s most up-to-date annual report on Kind 10-Ok and detailed infrequently in Bausch Well being’s different filings with the U.S. Securities and Change Fee and the Canadian Securities Directors, which elements are included herein by reference.
Additionally they embody, however aren’t restricted to, dangers and uncertainties attributable to or regarding the evolving COVID-19 pandemic, and the worry of that pandemic and its potential results, the severity, length and future impression of that are extremely unsure and can’t be predicted, and which can have a cloth opposed impression on Bausch Well being, together with however not restricted to its venture growth timelines, and prices (which can enhance). Readers are cautioned to not place undue reliance on any of those forward-looking statements.
These forward-looking statements converse solely as of the date hereof. Bausch Well being undertakes no obligation to replace any of those forward-looking statements to mirror occasions or circumstances after the date of this information launch or to mirror precise outcomes, except required by regulation.
®/TM are logos of Bausch Well being Firms Inc. or its associates, aside from XERESE which is a registered trademark of Meda Pharma S.A.R.L. used beneath license. Some other product/model names and/or logos are logos of the respective homeowners. © 2021 Bausch Well being Firms Inc. or its associates. ARE.0143.USA.21